Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA LUPIN TORRENT PHARMA/
LUPIN
 
P/E (TTM) x 56.9 40.2 141.7% View Chart
P/BV x 13.7 5.9 232.5% View Chart
Dividend Yield % 0.9 0.3 349.2%  

Financials

 TORRENT PHARMA   LUPIN
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
LUPIN
Mar-23
TORRENT PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,723799 215.6%   
Low Rs1,243583 213.1%   
Sales per share (Unadj.) Rs284.2365.8 77.7%  
Earnings per share (Unadj.) Rs36.89.8 373.9%  
Cash flow per share (Unadj.) Rs57.729.2 197.5%  
Dividends per share (Unadj.) Rs22.004.00 550.0%  
Avg Dividend yield %1.50.6 256.3%  
Book value per share (Unadj.) Rs183.1270.7 67.7%  
Shares outstanding (eoy) m338.45454.98 74.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.21.9 276.1%   
Avg P/E ratio x40.370.2 57.4%  
P/CF ratio (eoy) x25.723.7 108.6%  
Price / Book Value ratio x8.12.6 317.1%  
Dividend payout %59.840.7 147.1%   
Avg Mkt Cap Rs m501,779314,381 159.6%   
No. of employees `000NANA-   
Total wages/salary Rs m16,77730,872 54.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m96,202166,417 57.8%  
Other income Rs m6321,509 41.9%   
Total revenues Rs m96,834167,926 57.7%   
Gross profit Rs m28,24017,206 164.1%  
Depreciation Rs m7,0668,807 80.2%   
Interest Rs m3,3342,743 121.6%   
Profit before tax Rs m18,4727,165 257.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,0192,688 223.9%   
Profit after tax Rs m12,4524,477 278.1%  
Gross profit margin %29.410.3 283.9%  
Effective tax rate %32.637.5 86.9%   
Net profit margin %12.92.7 481.2%  
BALANCE SHEET DATA
Current assets Rs m53,137124,513 42.7%   
Current liabilities Rs m54,47392,654 58.8%   
Net working cap to sales %-1.419.1 -7.3%  
Current ratio x1.01.3 72.6%  
Inventory Days Days1526 59.1%  
Debtors Days Days798 7.5%  
Net fixed assets Rs m91,390103,490 88.3%   
Share capital Rs m1,692910 186.0%   
"Free" reserves Rs m60,288122,246 49.3%   
Net worth Rs m61,981123,156 50.3%   
Long term debt Rs m24,962275 9,073.9%   
Total assets Rs m144,682228,003 63.5%  
Interest coverage x6.53.6 181.1%   
Debt to equity ratio x0.40 18,029.8%  
Sales to assets ratio x0.70.7 91.1%   
Return on assets %10.93.2 344.6%  
Return on equity %20.13.6 552.7%  
Return on capital %25.18.0 312.5%  
Exports to sales %21.80-   
Imports to sales %00-   
Exports (fob) Rs m20,994NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m20,99448,057 43.7%   
Fx outflow Rs m3,73521,752 17.2%   
Net fx Rs m17,25926,306 65.6%   
CASH FLOW
From Operations Rs m23,68118,972 124.8%  
From Investments Rs m-24,153-12,868 187.7%  
From Financial Activity Rs m774-3,373 -22.9%  
Net Cashflow Rs m1,1012,732 40.3%  

Share Holding

Indian Promoters % 71.3 46.8 152.4%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 21.3 45.8 46.5%  
FIIs % 14.1 16.1 87.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.8 53.0 54.3%  
Shareholders   69,117 281,542 24.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Torrent Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Torrent Pharma vs Lupin Share Price Performance

Period Torrent Pharma Lupin S&P BSE HEALTHCARE
1-Day -2.09% -1.09% -1.12%
1-Month -3.88% 0.52% -5.16%
1-Year 65.13% 146.95% 57.23%
3-Year CAGR 27.77% 16.65% 18.08%
5-Year CAGR 21.86% 16.14% 18.84%

* Compound Annual Growth Rate

Here are more details on the Torrent Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Torrent Pharma hold a 71.3% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Torrent Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Torrent Pharma paid a dividend of Rs 22.0 per share. This amounted to a Dividend Payout ratio of 59.8%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Torrent Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.